Journal Of Drug Targeting SCIE

国际简称：J DRUG TARGET 参考译名：药物靶向杂志

主要研究方向：医学-药学非预警期刊审稿周期：约2月

《药物靶向杂志》(Journal Of Drug Targeting)是一本由Informa Healthcare出版的以医学-药学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q1 JCR分区
69 年发文量
4.3 IF影响因子
未开放 是否OA
80 H-index
1993 创刊年份
Bimonthly 出版周期
English 出版语言

Journal of Drug Targeting publishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.

Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Journal Of Drug Targeting期刊信息

ISSN：1061-186X
出版语言：English
是否OA：未开放
E-ISSN：1029-2330
出版地区：ENGLAND
是否预警：否
出版商：Informa Healthcare
出版周期：Bimonthly
创刊时间：1993
开源占比：0.0198
Gold OA文章占比：2.21%
OA被引用占比：0.0238...
出版国人文章占比：0.32
出版撤稿占比：0
研究类文章占比：44.93%

Journal Of Drug Targeting CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

9.1

0.849

0.706

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmaceutical Science	Q1	23 / 183	87%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Journal Of Drug Targeting中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学	4区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	PHARMACOLOGY & PHARMACY 药学	3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	PHARMACOLOGY & PHARMACY 药学	4区

Journal Of Drug Targeting JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	69 / 354	80.6%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	94 / 354	73.59%

Journal Of Drug Targeting历年数据统计

影响因子

中科院分区

Journal Of Drug Targeting中国学者发文选摘

1、TGF beta 1/integrin beta 3 positive feedback loop contributes to acquired EGFR TKI resistance in EGFR-mutant lung cancer
Author: Wang, Tao; Zhang, Yali; Cheng, Hanyue; Li, Ling; Xu, Lu

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 3, pp. 269-277. DOI: 10.1080/1061186X.2022.2064480
2、Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy
Author: Zhang, Yulu; Long, Yu; Wan, Jinyan; Liu, Songyu; Shi, Ai; Li, Dan; Yu, Shuang; Li, Xiaoqiu; Wen, Jing; Deng, Jie; Ma, Yin; Li, Nan

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 3, pp. 229-242. DOI: 10.1080/1061186X.2022.2071426
3、Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment
Author: Shi, Yanan; Liu, Lanze; Yin, Miaomiao; Zhao, Zhenyu; Liang, Yanzi; Sun, Kaoxiang; Li, Youxin

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 1, pp. 65-73. DOI: 10.1080/1061186X.2022.2104296
4、Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review
Author: Wei, Wuhao; Zhang, Yuansheng; Lin, Zhizhe; Wu, Xin; Fan, Wei; Chen, Jianming

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 1, pp. 1-13. DOI: 10.1080/1061186X.2022.2104299
5、Poly-gamma-glutamic acid coating polymeric nanoparticles enhance renal drug distribution and cellular uptake for diabetic nephropathy therapy
Author: Wang, Qili; Han, Shunping; Zhu, Yongqin; Wang, Guowei; Chen, Danfei

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 1, pp. 89-99. DOI: 10.1080/1061186X.2022.2106488
6、Nano-composite hydrogels of Cu-Apa micelles for anti-vasculogenic mimicry
Author: Kang, Rui; Song, Mengdi; Fang, Zhou; Liu, Kehai

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 2, pp. 166-178. DOI: 10.1080/1061186X.2022.2115047
7、Progress in research and development of temozolomide brain-targeted preparations: a review
Author: Yang, Jiefen; Xu, Youfa; Fu, Zhiqin; Chen, Jianming; Fan, Wei; Wu, Xin

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 2, pp. 119-133. DOI: 10.1080/1061186X.2022.2119243
8、Transdermal delivery of celecoxib and alpha-linolenic acid from microemulsion-incorporated dissolving microneedles for enhanced osteoarthritis therapy
Author: Li, Jian; Tian, Xin; Wang, Kang; Jia, Yong; Ma, Fuguang

Journal: JOURNAL OF DRUG TARGETING. 2023; Vol. 31, Issue 2, pp. 206-216. DOI: 10.1080/1061186X.2022.2123492